Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1972 Dec;25(12):1013–1033. doi: 10.1136/jcp.25.12.1013

The porphyrias: a review.

G H Elder, C H Gray, D C Nicholson
PMCID: PMC477614  PMID: 4570617

Full text

PDF
1013

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ACKNER B., COOPER J. E., GRAY C. H., KELLY M., NICHOLSON D. C. Excretion of porphobilinogen and 5-aminolaevulinic acid in acute porphyria. Lancet. 1961 Jun 10;1(7189):1256–1260. doi: 10.1016/s0140-6736(61)92764-7. [DOI] [PubMed] [Google Scholar]
  2. Aguadé J. P., Castells A., Indacochea A., Rodés J. A case of biochemically unclassifiable hepatic porphyria. Br J Dermatol. 1969 Apr;81(4):270–275. doi: 10.1111/j.1365-2133.1969.tb13979.x. [DOI] [PubMed] [Google Scholar]
  3. Allison A. C., Magnus I. A., Young M. R. Role of lysosomes and of cell membranes in photosensitization. Nature. 1966 Feb 26;209(5026):874–878. doi: 10.1038/209874a0. [DOI] [PubMed] [Google Scholar]
  4. Aziz M. A., Watson C. J. An analysis of the porphyrins of normal and cirrhotic human liver and normal bile. Clin Chim Acta. 1969 Dec;26(3):525–531. doi: 10.1016/0009-8981(69)90083-7. [DOI] [PubMed] [Google Scholar]
  5. BARNES H. D. Porphyria in South Africa: the faecal excretion of porphyrin. S Afr Med J. 1958 Jul 5;32(27):680–683. [PubMed] [Google Scholar]
  6. BERGER H., GOLDBERG A. Hereditary coproporphyria. Br Med J. 1955 Jul 9;2(4931):85–88. doi: 10.1136/bmj.2.4931.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. BERLIN N. I., NEUBERGER A., SCOTT J. J. The metabolism of delta -aminolaevulic acid. 2. Normal pathways, studied with the aid of 14C. Biochem J. 1956 Sep;64(1):90–100. doi: 10.1042/bj0640090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. BERMAN J., BIELICKY T. Einige äussere Faktoren in der Atilogie der Porphyria cutanea tarda und des Diabetes mellïtus mit besonderer Berücksichtigung der syphilitischen Infektion und ihrer Behandlung. Dermatologica. 1956 Aug;113(2):78–87. [PubMed] [Google Scholar]
  9. BOGORAD L. The enzymatic synthesis of porphyrins from porphobilinogen. II. Uroporphyrin III. J Biol Chem. 1958 Aug;233(2):510–515. [PubMed] [Google Scholar]
  10. BRUNSTING L. A., MASON H. L., ALDRICH R. A. Adult form of chronic porphyria with cutaneous manifestations; report of seventeen additional cases. J Am Med Assoc. 1951 Jul 28;146(13):1207–1212. doi: 10.1001/jama.1951.03670130029009. [DOI] [PubMed] [Google Scholar]
  11. BRUNSTING L. A. Observations on porphyria cutanea tarda. AMA Arch Derm Syphilol. 1954 Nov;70(5):551–564. doi: 10.1001/archderm.1954.01540230001001. [DOI] [PubMed] [Google Scholar]
  12. BURNHAM B. F., PIERCE W. S., WILLIAMS K. R., BOYER M. H., KIRBY C. K. delta-aminolaevulate dehydratase from Rhodopseudomonas spheroides. Biochem J. 1963 Jun;87:462–472. doi: 10.1042/bj0870462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Barnes H. D., Hurworth E., Millar J. H. Erythropoietic porphyrin hepatitis. J Clin Pathol. 1968 Mar;21(2):157–159. doi: 10.1136/jcp.21.2.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Becker D., Viljoen D., Kramer S. The inhibition of red cell and brain ATPase by delta-aminolaevulinic acid. Biochim Biophys Acta. 1971 Jan 5;225(1):26–34. doi: 10.1016/0005-2736(71)90280-x. [DOI] [PubMed] [Google Scholar]
  15. Belcher R. V., Smith S. G., Mahler R. Biliary protein-bound porphyrins in porphyria variegata. Clin Chim Acta. 1969 Jul;25(1):45–52. doi: 10.1016/0009-8981(69)90225-3. [DOI] [PubMed] [Google Scholar]
  16. Bloomer J. R., Berk P. D., Bonkowsky H. L., Stein J. A., Berlin N. I., Tschudy D. P. Blood volume and bilirubin production in acute intermittent porphyria. N Engl J Med. 1971 Jan 7;284(1):17–20. doi: 10.1056/NEJM197101072840104. [DOI] [PubMed] [Google Scholar]
  17. Bonkowsky H. L., Tschudy D. P., Collins A., Doherty J., Bossenmaier I., Cardinal R., Watson C. J. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin. Proc Natl Acad Sci U S A. 1971 Nov;68(11):2725–2729. doi: 10.1073/pnas.68.11.2725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Bossenmaier I., Cardinal R. Stability of delta-aminolevulinic acid and porphobilinogen in urine under varying conditions. Clin Chem. 1968 Jul;14(7):610–614. [PubMed] [Google Scholar]
  19. CALVERT R. J., RIMINGTON C. Porphyria cutanea tarda in relapse: a case report. Br Med J. 1953 Nov 21;2(4846):1131–1134. doi: 10.1136/bmj.2.4846.1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. CAN C., NIGOGOSYAN G. Acquired toxic porphyria cutanea tarda due to hexachlorobenzene. Report of 348 cases caused by this fungicide. JAMA. 1963 Jan 12;183:88–91. [PubMed] [Google Scholar]
  21. Chapel T. A., Stewart R. H., Webster S. B. Erythropoietic protoporphyria. Report of a case successfully treated with carotene. Arch Dermatol. 1972 Apr;105(4):572–573. doi: 10.1001/archderm.105.4.572. [DOI] [PubMed] [Google Scholar]
  22. Clark K. G., Nicholson D. C. Erythrocyte protoporphyrin and iron uptake in erythropoietic protoporphyria. Clin Sci. 1971 Oct;41(4):363–370. doi: 10.1042/cs0410363. [DOI] [PubMed] [Google Scholar]
  23. Cochrane A. L., Goldberg A. A study of faecal porphyrin levels in a large family. Ann Hum Genet. 1968 Oct;32(2):195–208. doi: 10.1111/j.1469-1809.1968.tb00064.x. [DOI] [PubMed] [Google Scholar]
  24. Connon J. J., Turkington V. Hereditary coproporphyria. Lancet. 1968 Aug 3;2(7562):263–264. doi: 10.1016/s0140-6736(68)92359-3. [DOI] [PubMed] [Google Scholar]
  25. Copeman P. W., Cripps D. J., Summerly R. Cutaneous hepatic porphyria and oestrogens. Br Med J. 1966 Feb 19;1(5485):461–463. doi: 10.1136/bmj.1.5485.461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Cripps D. J., MacEachern W. N. Hepatic and erythropoietic protoporphyria. Delta-aminolevulinic acid synthetase, fluorescence, and microfluorospectrophotometric study. Arch Pathol. 1971 Jun;91(6):497–505. [PubMed] [Google Scholar]
  27. Cripps D. J., Scheuer P. J. Hepatobiliary changes in erythropoietic protoporphyria. Arch Pathol. 1965 Nov;80(5):500–508. [PubMed] [Google Scholar]
  28. DEAN G., BARNES H. D. Porphyria in Sweden and South Africa. S Afr Med J. 1959 Mar 21;33(12):246–253. [PubMed] [Google Scholar]
  29. DEAN G. THE PREVALENCE OF THE PORPHYRIAS. S Afr J Lab Clin Med. 1963 Dec;14:145–151. [PubMed] [Google Scholar]
  30. DISCOMBE G., TREIP C. S. Cutaneous manifestations of porphyria. Br Med J. 1953 Nov 21;2(4846):1134–1136. doi: 10.1136/bmj.2.4846.1134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Donaldson E. M., McCall A. J., Magnus I. A., Simpson J. R., Caldwell R. A., Hargreaves T. Erythropoietic protoporphyria: two deaths from hepatic cirrhosis. Br J Dermatol. 1971 Jan;84(1):14–24. doi: 10.1111/j.1365-2133.1971.tb14191.x. [DOI] [PubMed] [Google Scholar]
  32. Doss M. Conversion of porphyrin methyl esters to zinc and copper chelates for spectrophotometric analysis. Anal Biochem. 1971 Jan;39(1):7–14. doi: 10.1016/0003-2697(71)90455-6. [DOI] [PubMed] [Google Scholar]
  33. Doss M. Formation of zinc chelates from porphyrin methyl esters for spectrophotometric analysis. Z Klin Chem Klin Biochem. 1970 May;8(3):208–211. doi: 10.1515/cclm.1970.8.3.208. [DOI] [PubMed] [Google Scholar]
  34. Doss M., Look D., Henning H. Chronic hepatic porphyria in chronic aggressive hepatitis. Klin Wochenschr. 1971 Jan;49(1):52–54. doi: 10.1007/BF01494070. [DOI] [PubMed] [Google Scholar]
  35. Doss M., Schmidt A. Quantitative Bestimmung von delta-Aminolävulinsäure und Porphobilinogen im Urin mit Ionenaustauschchromatographie-Fertigsäulen. Z Klin Chem Klin Biochem. 1971 Mar;9(2):99–102. [PubMed] [Google Scholar]
  36. Doss M., Ulshöfer B., Philipp-Dormston W. K. Quantitative thin-layer chromatography of porphyrins by in situ fluorescence measurements. J Chromatogr. 1971 Dec 9;63(1):113–120. doi: 10.1016/s0021-9673(01)85621-1. [DOI] [PubMed] [Google Scholar]
  37. Dowdle E. B., Mustard P., Eales L. Delta-aminolaevulinic acid synthetase activity in normal and porphyric human livers. S Afr Med J. 1967 Nov 4;41(42):1093–1096. [PubMed] [Google Scholar]
  38. Dowdle E., Goldswain P., Spong N., Eales L. The pattern of porphyrin isomer accumulation and excretion in symptomatic porphyria. Clin Sci. 1970 Aug;39(2):147–158. doi: 10.1042/cs0390147. [DOI] [PubMed] [Google Scholar]
  39. Dowdle E., Mustard P., Spong N., Eales L. The metabolism of (5-14C)delta-aminolaevulic acid in normal and porphyric human subjects. Clin Sci. 1968 Apr;34(2):233–251. [PubMed] [Google Scholar]
  40. EALES L., DOWDLE E. B., SAUNDERS S. J., SWEENEY G. D. THE DIAGNOSTIC IMPORTANCE OF FAECAL PORPHYRINS IN THE DIFFERENTIATION OF THE PORPHYRIAS. II. VALUES IN THE CUTANEOUS PORPHYRIAS. S Afr J Lab Clin Med. 1963 Sep;18:126–134. [PubMed] [Google Scholar]
  41. EALES L. PORPHYRIA AS SEEN IN CAPE TOWN. A SURVEY OF 250 PATIENTS AND SOME RECENT STUDIES. S Afr J Lab Clin Med. 1963 Dec;14:151–162. [PubMed] [Google Scholar]
  42. EDMONDSON P. R., SCHWARTZ S. Studies of the uroporphyrins. III. An improved method for the decarboxylation of uroporphyrin. J Biol Chem. 1953 Dec;205(2):605–609. [PubMed] [Google Scholar]
  43. ENGLAND M. T., COTTON V., FRENCH J. M. Faecal porphyrin excretion in normal subjects and in patients with the "malabsorption syndrome". Clin Sci. 1962 Jun;22:447–457. [PubMed] [Google Scholar]
  44. ERIKSEN L. Paper chromatographic separation of the coproporphyrin isomers I and III. Scand J Clin Lab Invest. 1958;10(3):319–322. [PubMed] [Google Scholar]
  45. Eales L., Dowdle E. B. Clinical aspects of importance in the porphyrias. Br J Clin Pract. 1968 Dec 12;22(12):505–515. [PubMed] [Google Scholar]
  46. Eales L., Dowdle E. B., Levey M. J., Sweeney G. D. The diagnostic importance of faecal porphyrins in the differentiation of the porphyrias. 3. South African genetic porphyria (variegcte porphyria)--the acute attack. S Afr Med J. 1966 May 7;40(17):380–382. [PubMed] [Google Scholar]
  47. Eales L., Dowdle E. B., Sweeney G. D. The acute porphyric attack. I. The electrolyte disorder of the acute porphyric attack and the possible role of delta-aminolaevulic acid. S Afr Med J. 1971 Sep 25;:89–97. [PubMed] [Google Scholar]
  48. Eales L., Grosser Y. The porphyrin peptides: practical implications. S Afr Med J. 1971 Sep 25;:160–166. [PubMed] [Google Scholar]
  49. Eales L. The acute porphyria attack. 3. Acute porphyria: the precipitating and aggravating factors. S Afr Med J. 1971 Sep 25;:120–125. [PubMed] [Google Scholar]
  50. Elder G. H. Identification of a group of tetracarboxylate porphyrins, containing one acetate and three propionate -substituents, in faeces from patients with symptomatic cutaneous hepatic porphyria and from rats with porphyria due to hexachlorobenzene. Biochem J. 1972 Feb;126(4):877–891. doi: 10.1042/bj1260877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Elder G. H. The porphyrin excretion pattern of symptomatic porphyria. S Afr Med J. 1971 Sep 25;:45–50. [PubMed] [Google Scholar]
  52. Epstein J. H., Redeker A. G. Porphyria cutanea tarda. A study of the effect of phlebotomy. N Engl J Med. 1968 Dec 12;279(24):1301–1304. doi: 10.1056/NEJM196812122792402. [DOI] [PubMed] [Google Scholar]
  53. FRENCH J. M., ENGLAND M. T., LINES J., THONGER E. SEPARATION OF ETHER-EXTRACTABLE FECAL PORPHYRINS BY COUNTER-CURRENT DISTRIBUTION. Arch Biochem Biophys. 1964 Sep;107:404–418. doi: 10.1016/0003-9861(64)90296-6. [DOI] [PubMed] [Google Scholar]
  54. Feldman D. S., Levere R. D., Lieberman J. S., Cardinal R. A., Watson C. J. Presynaptic neuromuscular inhibition by porphobilinogen and porphobilin. Proc Natl Acad Sci U S A. 1971 Feb;68(2):383–386. doi: 10.1073/pnas.68.2.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Felsher B. F., Redeker A. G. Effect of chloroquine on hepatic uroporphyrin metabolism in patients with porphyria cutanea tarda. Medicine (Baltimore) 1966 Nov;45(6):575–583. doi: 10.1097/00005792-196645060-00024. [DOI] [PubMed] [Google Scholar]
  56. French J. M., Thonger E. Ether-soluble porphyrins in bile, meconium and urine: a new appraisal by microscale counter-current analysis. Clin Sci. 1966 Dec;31(3):337–351. [PubMed] [Google Scholar]
  57. French J., Nicholson D. C., Rimington C. Identification of the acrylate porphyrin S-411 from meconium. Biochem J. 1970 Nov;120(2):393–397. doi: 10.1042/bj1200393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. GOLDBERG A. Acute intermittent porphyria: a study of 50 cases. Q J Med. 1959 Apr;28(110):183–209. [PubMed] [Google Scholar]
  59. GRANICK S., LEVERE R. D. HEME SYNTHESIS IN ERYTHROID CELLS. Prog Hematol. 1964;4:1–47. [PubMed] [Google Scholar]
  60. GRANICK S., URATA G. Increase in activity of alpha-aminolevulinic acid synthetase in liver mitochondria induced by feeding of 3,5-dicarbethoxy-1,4-dihydrocollidine. J Biol Chem. 1963 Feb;238:821–827. [PubMed] [Google Scholar]
  61. GRAY C. H., KULCZYCKA A., NICHOLSON D. C., MAGNUS I. A., RIMINGTON C. ISOTOPE STUDIES ON A CASE OF ERYTHROPOIETIC PROTOPORPHYRIA. Clin Sci. 1964 Feb;26:7–15. [PubMed] [Google Scholar]
  62. GRAY C. H., NEUBERGER A. Studies in congenital porphyria. I. Incorporation of 15N into coproporphyrin, uroporphyrin and hippuric acid. Biochem J. 1950 Jun-Jul;47(1):81–87. doi: 10.1042/bj0470081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Gheorghiu G., Forsea D. Berufliche aspekte bei der prophyria cutanea tarda. Berufsdermatosen. 1968 Oct;16(5):271–277. [PubMed] [Google Scholar]
  64. Goldberg A., Moore M. R., Beattie A. D., Hall P. E., McCallum J., Grant J. K. Excessive urinary excretion of certain porphyrinogenic steroids in human acute intermittent porphyria. Lancet. 1969 Jan 18;1(7586):115–118. doi: 10.1016/s0140-6736(69)91134-9. [DOI] [PubMed] [Google Scholar]
  65. Goldberg A., Rimington C., Lochhead A. C. Hereditary coproporphyria. Lancet. 1967 Mar 25;1(7491):632–636. doi: 10.1016/s0140-6736(67)92538-x. [DOI] [PubMed] [Google Scholar]
  66. Goldswain P., Dowdle E., Spong N., Eales L. The incorporation of [4-14C] delta-aminolaevulic acid into urinary porphyrins in symptomatic porphyria. Clin Sci. 1970 Aug;39(2):159–168. doi: 10.1042/cs0390159. [DOI] [PubMed] [Google Scholar]
  67. Grabecki J., Haduch T., Urbanowicz H. Die einfachen Bestimmungsmethoden der delta-Aminolävulinsäure im Harn. Int Arch Arbeitsmed. 1967;23(3):226–240. [PubMed] [Google Scholar]
  68. Granick S., Kappas A. Steroid induction of porphyrin synthesis in liver cell culture. I. Structural basis and possible physiological role in the control of heme formation. J Biol Chem. 1967 Oct 25;242(20):4587–4593. [PubMed] [Google Scholar]
  69. Granick S. The induction in vitro of the synthesis of delta-aminolevulinic acid synthetase in chemical porphyria: a response to certain drugs, sex hormones, and foreign chemicals. J Biol Chem. 1966 Mar 25;241(6):1359–1375. [PubMed] [Google Scholar]
  70. HAEGER B. Urinary delta-aminolaevulic acid and porphobilinogen in different types of porphyria. Lancet. 1958 Sep 20;2(7047):606–608. doi: 10.1016/s0140-6736(58)90334-9. [DOI] [PubMed] [Google Scholar]
  71. HEIKEL T., LOCKWOOD W. H., RIMINGTON C. Formation of non-enzymic haem. Nature. 1958 Aug 2;182(4631):313–313. doi: 10.1038/182313a0. [DOI] [PubMed] [Google Scholar]
  72. HEILMEYER L., CLOTTEN R. DIE KONGENITALE ERYTHROPOETISCHE COPROPORPHYRIE. EINE DRITTE ERYTHROPOETISCHE PORPHYRIEFORM. Dtsch Med Wochenschr. 1964 Apr 3;89:649–654. doi: 10.1055/s-0028-1111067. [DOI] [PubMed] [Google Scholar]
  73. HEILMEYER L., CLOTTEN R., KERP L., MERKER H., PARRA C. A., WETZEL H. P. PORPHYRIA ERYTHROPOETICA CONGENITA GUENTHER. BERICHT UEBER ZWEI FAMILIEN MIT ERFASSUNG DER MERKMALSTRAEGER. Dtsch Med Wochenschr. 1963 Dec 20;88:2449–2456. doi: 10.1055/s-0028-1112376. [DOI] [PubMed] [Google Scholar]
  74. HELLMAN E. S., TSCHUDY D. P., BARTTER F. C. Abnormal electrolyte and water metabolism in acute intermittent porphyria. The transient inappropriate secretion of antidiuretic hormone. Am J Med. 1962 May;32:734–746. doi: 10.1016/0002-9343(62)90163-8. [DOI] [PubMed] [Google Scholar]
  75. HOLTI G., RIMINGTON C., TATE B. C., THOMAS G. An investigation of porphyria cutanea tarda. Q J Med. 1958 Jan;27(105):1–18. [PubMed] [Google Scholar]
  76. Haeger-Aronsen B., Stathers G., Swahn G. Hereditary coproporphyria. Study of a Swedish family. Ann Intern Med. 1968 Aug;69(2):221–227. doi: 10.7326/0003-4819-69-2-221. [DOI] [PubMed] [Google Scholar]
  77. Hamnström B., Haeger-Aronsen B., Waldenström J., Hysing B., Molander J. Three Swedish families with porphyria variegata. Br Med J. 1967 Nov 25;4(5577):449–453. doi: 10.1136/bmj.4.5577.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Herbert F. K. Porphyrins excreted in various types of porphyria (with special reference to "pseudouroporphyrin"). Clin Chim Acta. 1966 Jan;13(1):19–30. doi: 10.1016/0009-8981(66)90260-9. [DOI] [PubMed] [Google Scholar]
  79. Hetherington G. W., Jetton R. L., Knox J. M. The association of lupus erythematosus and porphyria. Br J Dermatol. 1970 Feb;82(2):118–124. doi: 10.1111/j.1365-2133.1970.tb15001.x. [DOI] [PubMed] [Google Scholar]
  80. Hickman R., Saunders S. J., Eales L. Treatment of symptomatic porphyria by venesection. S Afr Med J. 1967 May 6;41(18):456–460. [PubMed] [Google Scholar]
  81. Hollander C. S., Scott R. L., Tschudy D. P., Perlroth M., Waxman A., Sterling K. Increased protein-bound iodine and thyroxine-binding globulin in acute intermittent porphyria. N Engl J Med. 1967 Nov 9;277(19):995–1000. doi: 10.1056/NEJM196711092771902. [DOI] [PubMed] [Google Scholar]
  82. Hunter J. A., Khan S. A., Hope E., Beattie A. D., Beveridge G. W., Smith A. W., Goldberg A. Hereditary coproporphyria. Photosensitivity, jaundice and neuropsychiatric manifestations associated with pregnancy. Br J Dermatol. 1971 Apr;84(4):301–310. doi: 10.1111/j.1365-2133.1971.tb14223.x. [DOI] [PubMed] [Google Scholar]
  83. IPPEN H. [General symptoms of late skin porphyria (porphyria cutanea tarda) as an indication for its treatment]. Dtsch Med Wochenschr. 1961 Jan 20;86:127–133. doi: 10.1055/s-0028-1112755. [DOI] [PubMed] [Google Scholar]
  84. JACOB F., MONOD J. Genetic regulatory mechanisms in the synthesis of proteins. J Mol Biol. 1961 Jun;3:318–356. doi: 10.1016/s0022-2836(61)80072-7. [DOI] [PubMed] [Google Scholar]
  85. Jean G., Lambertenghi G., Ranzi T. Ultrastructural study of the liver in hepatic prophyria. J Clin Pathol. 1968 Jul;21(4):501–507. doi: 10.1136/jcp.21.4.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Jones E. A., Bloomer J. R., Berlin N. I. The measurement of the synthetic rate of bilirubin from hepatic hemes in patients with acute intermittent porphyria. J Clin Invest. 1971 Nov;50(11):2259–2265. doi: 10.1172/JCI106723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Kalivas J. T., Pathak M. A., Fitzpatrick T. B. Phlebotomy and iron-overload in porphyria cutanea tarda. Lancet. 1969 Jun 14;1(7607):1184–1187. doi: 10.1016/s0140-6736(69)92167-9. [DOI] [PubMed] [Google Scholar]
  88. Kaufman L., Marver H. S. Biochemical defects in two types of human hepatic porphyria. N Engl J Med. 1970 Oct 29;283(18):954–958. doi: 10.1056/NEJM197010292831803. [DOI] [PubMed] [Google Scholar]
  89. Koskelo P., Toivonen I. Isomer type of free coproporphyrin in normal human erythrocytes. Clin Chim Acta. 1968 Aug;21(2):291–292. doi: 10.1016/0009-8981(68)90143-5. [DOI] [PubMed] [Google Scholar]
  90. LABBE R. F., HUBBARD N., CAUGHEY W. S. Porphyrin specificity of ferro:protoporphyrin chelatase from rat liver. Biochemistry. 1963 Mar-Apr;2:372–374. doi: 10.1021/bi00902a033. [DOI] [PubMed] [Google Scholar]
  91. LOCKWOOD W. H., DAVIES J. L. Paper electrophoresis of urinary porphyrins. Clin Chim Acta. 1962 May;7:301–308. doi: 10.1016/0009-8981(62)90028-1. [DOI] [PubMed] [Google Scholar]
  92. Landaw S. A., Callahan E. W., Jr, Schmid R. Catabolism of heme in vivo: comparison of the simultaneous production of bilirubin and carbon monoxide. J Clin Invest. 1970 May;49(5):914–925. doi: 10.1172/JCI106311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Lees R. S., Song C. S., Levere R. D., Kappas A. Hyperbeta-lipoproteinemia in acute intermittent porphyria; preliminary report. N Engl J Med. 1970 Feb 19;282(8):432–433. doi: 10.1056/NEJM197002192820807. [DOI] [PubMed] [Google Scholar]
  94. Lomholt J. C., With T. K. Hereditary coproporphyria. A family with unusually few and mild symptoms. Acta Med Scand. 1969 Jul-Aug;186(1-2):83–85. [PubMed] [Google Scholar]
  95. Lundvall O., Enerbäck L. Hepatic fluorescence in porphyria cutanea tarda studied in fine needle aspiration biopsy smears. J Clin Pathol. 1969 Nov;22(6):704–709. doi: 10.1136/jcp.22.6.704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Lundvall O., Weinfeld A. Studies of the clinical and metabolic effects of phlebotomy treatment in porphyria cutanea tarda. Acta Med Scand. 1968 Sep;184(3):191–199. doi: 10.1111/j.0954-6820.1968.tb02443.x. [DOI] [PubMed] [Google Scholar]
  97. MACGREGOR A. G., NICHOLAS R. E. H., RIMINGTON C. Porphyria cutanea tarda; investigation of a case, including isolation of some hitherto undescribed porphyrins. AMA Arch Intern Med. 1952 Oct;90(4):483–504. doi: 10.1001/archinte.1952.00240100060006. [DOI] [PubMed] [Google Scholar]
  98. MAGNUS I. A., JARRETT A., PRANKERD T. A., RIMINGTON C. Erythropoietic protoporphyria. A new porphyria syndrome with solar urticaria due to protoporphyrinaemia. Lancet. 1961 Aug 26;2(7200):448–451. doi: 10.1016/s0140-6736(61)92427-8. [DOI] [PubMed] [Google Scholar]
  99. MAUZERALL D., GRANICK S. The occurrence and determination of delta-amino-levulinic acid and porphobilinogen in urine. J Biol Chem. 1956 Mar;219(1):435–446. [PubMed] [Google Scholar]
  100. MONOD J., CHANGEUX J. P., JACOB F. Allosteric proteins and cellular control systems. J Mol Biol. 1963 Apr;6:306–329. doi: 10.1016/s0022-2836(63)80091-1. [DOI] [PubMed] [Google Scholar]
  101. Magnus I. A., Wood M. X-porphyrins and the porphyrias. Trans St Johns Hosp Dermatol Soc. 1971;57(1):105–114. [PubMed] [Google Scholar]
  102. Marver H. S., Schmid R. Biotransformation in the liver: implications for human disease. Gastroenterology. 1968 Aug;55(2):282–289. [PubMed] [Google Scholar]
  103. Masuya T. Pathophysiological observations on porphyrias. Nihon Ketsueki Gakkai Zasshi. 1969 Aug;32(4):519–568. [PubMed] [Google Scholar]
  104. McIntyre N., Pearson A. J., Allan D. J., Craske S., West G. M., Moore M. R., Beattie A. D., Paxton J., Goldberg A. Hepatic delta-aminolaevulinic acid synthetase in an attack of hereditary coproporphyria and during remission. Lancet. 1971 Mar 20;1(7699):560–564. doi: 10.1016/s0140-6736(71)91161-5. [DOI] [PubMed] [Google Scholar]
  105. McKenzie A. W., Acharya U. The oral contraceptive and variegate porphyria. Br J Dermatol. 1972 May;86(5):453–457. doi: 10.1111/j.1365-2133.1972.tb16096.x. [DOI] [PubMed] [Google Scholar]
  106. Meyer U. A., Strand L. J., Doss M., Rees A. C., Marver H. S. Intermittent acute porphyria--demonstration of a genetic defect in porphobilinogen metabolism. N Engl J Med. 1972 Jun 15;286(24):1277–1282. doi: 10.1056/NEJM197206152862401. [DOI] [PubMed] [Google Scholar]
  107. Miyagi K., Cardinal R., Bossenmaier I., Watson C. J. The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals. J Lab Clin Med. 1971 Nov;78(5):683–695. [PubMed] [Google Scholar]
  108. Moore M. R., Thompson G. G., Goldberg A. Amounts of faecal porphyrin-peptide conjugates in the porpyrias. Clin Sci. 1972 Aug;43(2):299–302. doi: 10.1042/cs0430299. [DOI] [PubMed] [Google Scholar]
  109. Moore M. R., Turnbull A. L., Barnardo D., Beattie A. D., Magnus I. A., Goldberg A. Hepatic -aminolaevulinic acid synthetase activity in porphyria cutanea tarda. Lancet. 1972 Jul 15;2(7768):97–100. doi: 10.1016/s0140-6736(72)91593-0. [DOI] [PubMed] [Google Scholar]
  110. NIELSEN B., THORN N. A. TRANSIENT EXCESS URINARY EXCRETION OF ANTIDIURETIC MATERIAL IN ACUTE INTERMITTENT PORPHYRIA WITH HYPONATREMIA AND HYPOMAGNESEMIA. Am J Med. 1965 Mar;38:345–358. doi: 10.1016/0002-9343(65)90144-0. [DOI] [PubMed] [Google Scholar]
  111. Nacht S., San Martín de Viale L. C., Grinstein M. Human porphyria cutanea tarda. Isolation and properties of the urinary porphyrins. Clin Chim Acta. 1970 Mar;27(3):445–452. doi: 10.1016/0009-8981(70)90297-4. [DOI] [PubMed] [Google Scholar]
  112. Nakao K., Wada O., Kitamura T., Uono K., Urata G. Activity of amino-laevulinic acid synthetase in normal and porphyric human livers. Nature. 1966 May 21;210(5038):838–839. doi: 10.1038/210838b0. [DOI] [PubMed] [Google Scholar]
  113. Neuberger A. Biochemical basis and regulatory mechanisms of porphyrin synthesis. Proc R Soc Med. 1968 Feb;61(2):191–193. [PMC free article] [PubMed] [Google Scholar]
  114. Perlroth M. G., Tschudy D. P., Marver H. S., Berard C. W., Zeigel R. F., Rechcigl M., Collins A. Acute intermittent porphyria. New morphologic and biochemical findings. Am J Med. 1966 Jul;41(1):149–162. doi: 10.1016/0002-9343(66)90012-x. [DOI] [PubMed] [Google Scholar]
  115. Perlroth M. G., Tschudy D. P., Waxman A., Odell W. D. Abnormalities of growth hormone regulation in acute intermittent porphyria. Metabolism. 1967 Jan;16(1):87–90. doi: 10.1016/0026-0495(67)90163-1. [DOI] [PubMed] [Google Scholar]
  116. Perman G. Hemochromatosis and red wine. Acta Med Scand. 1967 Sep;182(3):281–284. doi: 10.1111/j.0954-6820.1967.tb11524.x. [DOI] [PubMed] [Google Scholar]
  117. Prentice R. T., Goldberg A., Thompson G. Photosensitivity: familial incidence, clinical features and incidence of erythropoietic protoporphyria. Br J Dermatol. 1969 Jun;81(6):414–419. doi: 10.1111/j.1365-2133.1969.tb14010.x. [DOI] [PubMed] [Google Scholar]
  118. RIMINGTON C., CRIPPS D. J. BIOCHEMICAL AND FLUORESCENCE-MICROSCOPY SCREENING-TESTS FOR ERYTHROPOIETIC PROTOPORPHYRIA. Lancet. 1965 Mar 20;1(7386):624–626. doi: 10.1016/s0140-6736(65)91714-9. [DOI] [PubMed] [Google Scholar]
  119. RIMINGTON C. Haems and prophyrins in health and disease. Acta Med Scand. 1952 May 26;143(3):161–196. [PubMed] [Google Scholar]
  120. RIMINGTON C., MILES P. A. A study of the porphyrins excreted in the urine by a case of congenital porphyria. Biochem J. 1951 Dec;50(2):202–206. doi: 10.1042/bj0500202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. RIMINGTON C. Types of porphyria: some thoughts about biochemical mechanisms involved. Ann N Y Acad Sci. 1963 Mar 5;104:666–675. doi: 10.1111/j.1749-6632.1963.tb17700.x. [DOI] [PubMed] [Google Scholar]
  122. ROSE J. A., HELLMAN E. S., TSCHUDY D. P. Effect of diet on induction of experimental porphyria. Metabolism. 1961 Jul;10:514–521. [PubMed] [Google Scholar]
  123. Ridley A. The neuropathy of acute intermittent porphyria. Q J Med. 1969 Jul;38(151):307–333. [PubMed] [Google Scholar]
  124. Rifkind A. B., Gillette P. N., Song C. S., Kappas A. Induction of hepatic delta-amino-levulinic acid synthetase by oral contraceptive steroids. J Clin Endocrinol Metab. 1970 Mar;30(3):330–335. doi: 10.1210/jcem-30-3-330. [DOI] [PubMed] [Google Scholar]
  125. Rimington C., Lockwood W. H., Belcher R. V. The excretion of porphyrin-peptide conjugates in porphyria variegata. Clin Sci. 1968 Oct;35(2):211–247. [PubMed] [Google Scholar]
  126. Rimington C., Smears W. G., Eales L. Symptomatic porphyria in a case of Felty's syndrome. II. Biochemical investigations. Clin Chem. 1972 May;18(5):462–470. [PubMed] [Google Scholar]
  127. Roenigk H. H., Jr, Gottlob M. E. Estrogen-induced porphyria cutanea tarda. Report of three cases. Arch Dermatol. 1970 Sep;102(3):260–266. [PubMed] [Google Scholar]
  128. Romeo G., Glenn B. L., Levin E. Y. Uroporphyrinogen 3 cosynthetase in asymptomatic carriers of congenital erythpoietic porphyria. Biochem Genet. 1970 Dec;4(6):719–726. doi: 10.1007/BF00486385. [DOI] [PubMed] [Google Scholar]
  129. Romeo G., Kaback M. M., Levin E. Y. Uroporphyrinogen 3 cosynthetase activity in fibroblasts from patients with congenital erythropoietic porphyria. Biochem Genet. 1970 Dec;4(6):659–664. doi: 10.1007/BF00486379. [DOI] [PubMed] [Google Scholar]
  130. SANO S., GRANICK S. Mitochondrial coproporphyrinogen oxidase and protoporphyrin formation. J Biol Chem. 1961 Apr;236:1173–1180. [PubMed] [Google Scholar]
  131. SAUNDERS S. J. IRON METABOLISM IN SYMPTOMATIC PORPHYRIA. A PRELIMINARY COMMUNICATION. S Afr J Lab Clin Med. 1963 Dec;14:277–282. [PubMed] [Google Scholar]
  132. SCHMID R., SCHWARTZ S., SUNDBERG R. D. Erythropoietic (congenital) porphyria: A rare abnormality of the normoblasts. Blood. 1955 May;10(5):416–428. [PubMed] [Google Scholar]
  133. SCHMID R., SCHWARTZ S., WATSON C. J. Porphyrin content of bone marrow and liver in the various forms of porphyria. AMA Arch Intern Med. 1954 Feb;93(2):167–190. doi: 10.1001/archinte.1954.00240260001001. [DOI] [PubMed] [Google Scholar]
  134. SWEENEY G. D. PATTERNS OF PORPHYRIN EXCRETION IN SOUTH AFRICA PORPHYRIC PATIENTS. S Afr J Lab Clin Med. 1963 Dec;14:182–190. [PubMed] [Google Scholar]
  135. SWEENEY G. D., SAUNDERS S. J., DOWDLE E. B., EALES L. EFFECTS OF CHLOROQUINE ON PATIENTS WITH CUTANEOUS PORPHYRIA OF THE "SYMPTOMATIC" TYPE. Br Med J. 1965 May 15;1(5445):1281–1285. doi: 10.1136/bmj.1.5445.1281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Scholnick P., Marver H. S., Schmid R. Erythropoietic protoporphyria: evidence for multiple sites of excess protoporphyrin formation. J Clin Invest. 1971 Jan;50(1):203–207. doi: 10.1172/JCI106474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Schwartz S., Johnson J. A., Stephenson B. D., Anderson A. S., Edmondson P. R., Fusaro R. M. Erythropoietic defects in protoporphyria: a study of factors involved in labelling of porphyrins and bile pigments from ALA- 3 H and glycine- 14 C. J Lab Clin Med. 1971 Sep;78(3):411–434. [PubMed] [Google Scholar]
  138. Shanley B. C., Zail S. S., Joubert S. M. Effect of ethanol on liver delta-aminolaevulinate synthetase activity and urinary porphyrin excretion in symptomatic porphyria. Br J Haematol. 1969 Oct;17(4):389–396. doi: 10.1111/j.1365-2141.1969.tb01384.x. [DOI] [PubMed] [Google Scholar]
  139. Shanley B. C., Zail S. S., Joubert S. M. Porphyrin metabolism in experimental hepatic siderosis in the rat. Br J Haematol. 1970 Jan;18(1):79–87. doi: 10.1111/j.1365-2141.1970.tb01420.x. [DOI] [PubMed] [Google Scholar]
  140. Smith S. C., Belcher R. V., Mahler R., Yudkin J. Bile and faecal porphyrins in the quiescent phase of variegate porphyria. Biochem J. 1968 Nov;110(2):15P–15P. doi: 10.1042/bj1100015pa. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Sorensen A. W., With T. K. Persistent pareses after porphyric attacks. S Afr Med J. 1971 Sep 25;:101–103. [PubMed] [Google Scholar]
  142. Stein J. A., Bloomer J. R., Berk P. D., Corcoran P. L., Tschudy D. P. The kinetics of organic anion excretion by the liver in acute intermittent porphyria. Clin Sci. 1970 Jun;38(6):677–686. doi: 10.1042/cs0380677. [DOI] [PubMed] [Google Scholar]
  143. Stein J. A., Tschudy D. P. Acute intermittent porphyria. A clinical and biochemical study of 46 patients. Medicine (Baltimore) 1970 Jan;49(1):1–16. [PubMed] [Google Scholar]
  144. Strand L. J., Felsher B. F., Redeker A. G., Marver H. S. Heme biosynthesis in intermittent acute prophyria: decreased hepatic conversion of porphobilinogen to porphyrins and increased delta aminolevulinic acid synthetase activity. Proc Natl Acad Sci U S A. 1970 Nov;67(3):1315–1320. doi: 10.1073/pnas.67.3.1315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Strand L. J., Manning J., Marver H. S. Acute intermittent porphyria: studies of the enzymatic basis of disordered haem biosynthesis. S Afr Med J. 1971 Sep 25;:108–111. [PubMed] [Google Scholar]
  146. THEOLOGIDES A., KENNEDY B. J., WATSON C. J. A STUDY OF THE URINARY PORPHYRINS AND PORPHYRIN PRECURSORS IN PATIENTS WITH MALIGNANT DISEASE RECEIVING DIETHYLSTILBESTROL. Metabolism. 1964 May;13:391–395. doi: 10.1016/0026-0495(64)90112-x. [DOI] [PubMed] [Google Scholar]
  147. TIO T. H., LEIJNSE B., JARRETT A., RIMINGTON C. Acquired porphyria from a liver tumour. Clin Sci. 1957 Aug;16(3):517–527. [PubMed] [Google Scholar]
  148. TSCHUDY D. P., PERLROTH M. G., MARVER H. S., COLLINS A., HUNTER G., Jr, RECHCIGL M., Jr ACUTE INTERMITTENT PORPHYRIA: THE FIRST "OVERPRODUCTION DISEASE" LOCALIZED TO A SPECIFIC ENZYME. Proc Natl Acad Sci U S A. 1965 Apr;53:841–847. doi: 10.1073/pnas.53.4.841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Taddeini L., Watson C. J. The clinical porphyrias. Semin Hematol. 1968 Oct;5(4):335–369. [PubMed] [Google Scholar]
  150. Taljaard J. J., Shanley B. C., Joubert S. M. Decreased uroporphyrinogen decarboxylase activity in 'experimental symptomatic porphyria'. Life Sci II. 1971 Aug;10(15):887–893. [PubMed] [Google Scholar]
  151. Thompson R. P., Nicholson D. C., Farnan T., Whitmore D. N., Williams R. Cutaneous porphyria due to a malignant primary hepatoma. Gastroenterology. 1970 Nov;59(5):779–783. [PubMed] [Google Scholar]
  152. Timme A. H. The ultrastructure of the liver in human symptomatic porphyria. A preliminary communication. S Afr Med J. 1971 Sep 25;:58–62. [PubMed] [Google Scholar]
  153. Tschudy D. P., Bonkowsky H. L. Experimental porphyria. Fed Proc. 1972 Jan-Feb;31(1):147–159. [PubMed] [Google Scholar]
  154. Tschudy D. P., Waxman A., Collins A. Oscillations of hepatic delta-aminolevulinic acid synthetase produced by estrogen: a possible role of "rebound induction" in biological clock mechanisms. Proc Natl Acad Sci U S A. 1967 Nov;58(5):1944–1948. doi: 10.1073/pnas.58.5.1944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Turnbull A. Iron metabolism in the porphyrias. Br J Dermatol. 1971 Apr;84(4):380–383. doi: 10.1111/j.1365-2133.1971.tb14237.x. [DOI] [PubMed] [Google Scholar]
  156. UYS C. J., EALES L. THE HISTOPATHOLOGY OF THE LIVER IN ACQUIRED (SYMPTOMATIC) PORPHYRIA. S Afr J Lab Clin Med. 1963 Dec;14:190–197. [PubMed] [Google Scholar]
  157. Vail J. T., Jr Porphyria cutanea tarda and estrogens. JAMA. 1967 Aug 28;201(9):671–674. [PubMed] [Google Scholar]
  158. WALDENSTROM J., HAEGER-ARONSEN B. Different patterns of human porphyria. Br Med J. 1963 Aug 3;2(5352):272–276. doi: 10.1136/bmj.2.5352.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. WALDENSTROM J., HAEGER B. The liver in porphyria cutanea tarda. Ann Intern Med. 1960 Aug;53:286–292. doi: 10.7326/0003-4819-53-2-286. [DOI] [PubMed] [Google Scholar]
  160. WALDENSTROM J. The porphyrias as inborn errors of metabolism. Am J Med. 1957 May;22(5):758–773. doi: 10.1016/0002-9343(57)90126-2. [DOI] [PubMed] [Google Scholar]
  161. WARIN R. P. PORPHYRIA CUTANEA TARDA ASSOCIATED WITH OESTROGEN THERAPY FOR PROSTATIC CARCINOMA. Br J Dermatol. 1963 Jul;75:298–299. [PubMed] [Google Scholar]
  162. WATSON C. J., LOWRY P. T., SCHMID R., HAWKINSON V. E., SCHWARTZ S. The manifestations of the different forms of porphyria in relation to chemical findings. Trans Assoc Am Physicians. 1951;64:345–352. [PubMed] [Google Scholar]
  163. WATSON C. J. Porphyria. Adv Intern Med. 1954;6:235–299. [PubMed] [Google Scholar]
  164. WATSON C. J., RUNGE W., TADDEINI L., BOSSENMAIER I., CARDINAL R. A SUGGESTED CONTROL GENE MECHANISM FOR THE EXCESSIVE PRODUCTION OF TYPES I AND 3 PORPHYRINS IN CONGENITAL ERYTHROPOIETIC PORPHYRIA. Proc Natl Acad Sci U S A. 1964 Aug;52:478–485. doi: 10.1073/pnas.52.2.478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. WATSON C. J. Some recent studies of porphyrin metabolism and porphyria. Lancet. 1951 Mar 10;1(6654):539–542. doi: 10.1016/s0140-6736(51)92241-6. [DOI] [PubMed] [Google Scholar]
  166. WATSON C. J. The problem of porphyria--some facts and questions. N Engl J Med. 1960 Dec 15;263:1205–1215. doi: 10.1056/NEJM196012152632401. [DOI] [PubMed] [Google Scholar]
  167. WELLAND F. H., HELLMAN E. S., GADDIS E. M., COLLINS G., HUNTER G. W., Jr, TSCHUDY D. P. FACTORS AFFECTING THE EXCRETION OF PORPHYRIN PRECURSORS BY PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA. I. THE EFFECT OF DIET. Metabolism. 1964 Mar;13:232–250. doi: 10.1016/0026-0495(64)90103-9. [DOI] [PubMed] [Google Scholar]
  168. WELLS G. C., RIMINGTON C. Studies on a case of porphyria cutanea tarda. Br J Dermatol. 1953 Oct;65(10):337–351. doi: 10.1111/j.1365-2133.1953.tb13165.x. [DOI] [PubMed] [Google Scholar]
  169. WETTERBERG L. ORAL CONTRACEPTIVES AND ACUTE INTERMITTENT PORPHYRIA. Lancet. 1964 Nov 28;2(7370):1178–1179. doi: 10.1016/s0140-6736(64)92706-0. [DOI] [PubMed] [Google Scholar]
  170. WITH T. K. Excretion of porphobilinogen and Delta-aminolaevulinic acid in acute porphyria. Lancet. 1961 Aug 26;2(7200):485–486. doi: 10.1016/s0140-6736(61)92451-5. [DOI] [PubMed] [Google Scholar]
  171. Waldenström J., Haeger-Aronsen B. The porphyrias: a genetic problem. Prog Med Genet. 1967;5:58–101. doi: 10.1016/b978-1-4831-6757-2.50006-3. [DOI] [PubMed] [Google Scholar]
  172. Watson C. J., Schwartz S., Schulze W., Jacobson L. O., Zagaria R. STUDIES OF COPROPORPHYRIN. III. IDIOPATHIC COPROPORPHYRINURIA; A HITHERTO UNRECOGNIZED FORM CHARACTERIZED BY LACK OF SYMPTOMS IN SPITE OF THE EXCRETION OF LARGE AMOUNTS OF COPROPORPHYRIN. J Clin Invest. 1949 May;28(3):465–468. doi: 10.1172/JCI102091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Watson C. J. The question of hepatic or ubiquitous versus erythropoietic origin of the excessive porphyrin in porphyria congenita erythropoietica. Panminerva Med. 1968 Mar;10(3):110–113. [PubMed] [Google Scholar]
  174. Waxman A. D., Berk P. D., Schalch D., Tschudy D. P. Isolated adrenocorticotrophic hormone deficiency in acute intermittent porphyria. Ann Intern Med. 1969 Feb;70(2):317–323. doi: 10.7326/0003-4819-70-2-317. [DOI] [PubMed] [Google Scholar]
  175. With T. K. Hereditary hepatic prophyrias. Gene penetration, drug sensitivity and subdivision in the light of systematic family studies. Acta Med Scand. 1969 Jul-Aug;186(1-2):117–124. [PubMed] [Google Scholar]
  176. Zail S. S., Joubert S. M. Hepatic delta-aminolaevulinic acid synthetase activity in symptomatic porphyria. Br J Haematol. 1968 Aug;15(2):123–129. doi: 10.1111/j.1365-2141.1968.tb01521.x. [DOI] [PubMed] [Google Scholar]
  177. Zimmerman T. S., McMillin J. M., Watson C. J. Onset of manifestations of hepatic porphyria in relation to the influence of female sex hormones. Arch Intern Med. 1966 Sep;118(3):229–240. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES